Drug Profile
Mitiglinide/metformin
Alternative Names: MetglunaLatest Information Update: 08 Oct 2010
Price :
$50
*
At a glance
- Originator Kissei Pharmaceutical
- Developer Elixir Pharmaceuticals
- Class Antihyperglycaemics; Biguanides; Isoindoles
- Mechanism of Action AMP activated protein kinase stimulants; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus